标题
A strategy for risk mitigation of antibodies with fast clearance
作者
关键词
-
出版物
mAbs
Volume 4, Issue 6, Pages 753-760
出版商
Informa UK Limited
发表日期
2012-11-02
DOI
10.4161/mabs.22189
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Marketed therapeutic antibodies compendium
- (2012) Janice M. Reichert mAbs
- The Influence of Charge Distribution on Self-Association and Viscosity Behavior of Monoclonal Antibody Solutions
- (2012) Sandeep Yadav et al. MOLECULAR PHARMACEUTICS
- Monoclonal Antibodies with Identical Fc Sequences Can Bind to FcRn Differentially with Pharmacokinetic Consequences
- (2011) W. Wang et al. DRUG METABOLISM AND DISPOSITION
- Highly specific off-target binding identified and eliminated during the humanization of an antibody against FGF receptor 4
- (2011) Daniela Bumbaca et al. mAbs
- Neonatal Fc receptor and IgG-based therapeutics
- (2011) Timothy T. Kuo et al. mAbs
- Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data
- (2011) Rong Deng et al. mAbs
- Complex Pharmacokinetics of a Humanized Antibody Against Human Amyloid Beta Peptide, Anti-Abeta Ab2, in Nonclinical Species
- (2011) Yulia Vugmeyster et al. PHARMACEUTICAL RESEARCH
- Efficient production of antibodies against a mammalian integral membrane protein by phage display
- (2011) Isidro Hötzel et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies
- (2010) Diane R. Mould et al. BIODRUGS
- A Therapeutic Anti-VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life
- (2010) Y. A. Yeung et al. CANCER RESEARCH
- Clinical Pharmacokinetics of Therapeutic Monoclonal Antibodies
- (2010) Ron J. Keizer et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics of Humanized Monoclonal Anti-Tumor Necrosis Factor- Antibody and Its Neonatal Fc Receptor Variants in Mice and Cynomolgus Monkeys
- (2010) R. Deng et al. DRUG METABOLISM AND DISPOSITION
- Proteomics of the Autographa californica Nucleopolyhedrovirus Budded Virions
- (2010) R. Wang et al. JOURNAL OF VIROLOGY
- In vitro potency, pharmacokinetic profiles and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus
- (2010) Yulia Vugmeyster et al. mAbs
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- Reduced elimination of IgG antibodies by engineering the variable region
- (2010) T. Igawa et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Engineering Human IgG1 Affinity to Human Neonatal Fc Receptor: Impact of Affinity Improvement on Pharmacokinetics in Primates
- (2009) Y. A. Yeung et al. JOURNAL OF IMMUNOLOGY
- Monoclonal Antibody Pharmacokinetics and Pharmacodynamics
- (2008) W Wang et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More